Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts using a Humanized anti-Fibroblast Activation Protein Antibody.
Kobayashi T, Noma K, Nishimura S, Kato T, Nishiwaki N, Ohara T, Kunitomo T, Kawasaki K, Akai M, Komoto S, Kashima H, Kikuchi S, Tazawa H, Shirakawa Y, Choyke PL, Kobayashi H, Fujiwara T. Kobayashi T, et al. Among authors: tazawa h. Mol Cancer Ther. 2024 Apr 18. doi: 10.1158/1535-7163.MCT-23-0527. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38638034
Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Watanabe S, Noma K, Ohara T, Kashima H, Sato H, Kato T, Urano S, Katsube R, Hashimoto Y, Tazawa H, Kagawa S, Shirakawa Y, Kobayashi H, Fujiwara T. Watanabe S, et al. Among authors: tazawa h. Cancer Biol Ther. 2019;20(9):1234-1248. doi: 10.1080/15384047.2019.1617566. Epub 2019 Jun 11. Cancer Biol Ther. 2019. PMID: 31185791 Free PMC article.
Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
Katsube R, Noma K, Ohara T, Nishiwaki N, Kobayashi T, Komoto S, Sato H, Kashima H, Kato T, Kikuchi S, Tazawa H, Kagawa S, Shirakawa Y, Kobayashi H, Fujiwara T. Katsube R, et al. Among authors: tazawa h. Sci Rep. 2021 Jan 18;11(1):1693. doi: 10.1038/s41598-021-81465-4. Sci Rep. 2021. PMID: 33462372 Free PMC article.
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M, Noma K, Kato T, Nishimura S, Matsumoto H, Kawasaki K, Kunitomo T, Kobayashi T, Nishiwaki N, Kashima H, Kikuchi S, Ohara T, Tazawa H, Choyke PL, Kobayashi H, Fujiwara T. Akai M, et al. Among authors: tazawa h. Br J Cancer. 2024 Jun;130(10):1647-1658. doi: 10.1038/s41416-024-02639-1. Epub 2024 Mar 30. Br J Cancer. 2024. PMID: 38555315 Free PMC article.
Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells.
Shimoyama K, Kagawa S, Ishida M, Watanabe S, Noma K, Takehara K, Tazawa H, Hashimoto Y, Tanabe S, Matsuoka J, Kobayashi H, Fujiwara T. Shimoyama K, et al. Among authors: tazawa h. Breast Cancer Res Treat. 2015 Feb;149(3):597-605. doi: 10.1007/s10549-015-3265-y. Epub 2015 Jan 24. Breast Cancer Res Treat. 2015. PMID: 25616354
Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer.
Takehara K, Tazawa H, Okada N, Hashimoto Y, Kikuchi S, Kuroda S, Kishimoto H, Shirakawa Y, Narii N, Mizuguchi H, Urata Y, Kagawa S, Fujiwara T. Takehara K, et al. Among authors: tazawa h. Mol Cancer Ther. 2016 Jan;15(1):199-208. doi: 10.1158/1535-7163.MCT-15-0344. Epub 2015 Dec 1. Mol Cancer Ther. 2016. PMID: 26625896
Iron depletion enhances the effect of sorafenib in hepatocarcinoma.
Urano S, Ohara T, Noma K, Katsube R, Ninomiya T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F, Nouso K, Matsukawa A, Yamamoto K, Fujiwara T. Urano S, et al. Among authors: tazawa h. Cancer Biol Ther. 2016 Jun 2;17(6):648-56. doi: 10.1080/15384047.2016.1177677. Epub 2016 Apr 18. Cancer Biol Ther. 2016. PMID: 27089255 Free PMC article.
398 results